Carb-X global antibacterial accelerator OTA
Active Definitive Contract Awarded Last action
- Contract number
- 75A50122C00028
- Awardee
-
Trustees Of Boston University UEI THL6A6JLE1S7
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $150,780,000
Award facts
- Opportunity
-
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Pre-Solicitation · BAA18100SOL00003 · Posted Oct 16, 2017
- Contract value 50% obligated
-
- $150,780,000.00 Current, with exercised options
- $300,000,000.00 Potential, with all options
- Completion date 44% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Boston, MA 02215, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $10,780,000 | |
| Change Order | $0 | |
| Exercise an Option | $33,000,000 | |
| Exercise an Option | $22,000,000 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $20,000,000 | |
| Exercise an Option | $40,000,000 | |
| Supplemental Agreement for work within scope | $5,000,000 | |
| Other Administrative Action | $0 | |
| Original award | $20,000,000 |
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded a $300 million definitive contract to Trustees of Boston University for the CARB-X Global Antibacterial Accelerator OTA on June 1, 2022, under a cost-no-fee pricing structure with an ultimate completion date of May 31, 2032.
The contract operates as an Other Transaction Agreement (OTA) with no set-aside designation. Place of performance is Boston, MA. The originating solicitation describes a Broad Agency Announcement from the Biomedical Advanced Research and Development Authority seeking proposals for advanced research and development of medical countermeasures against biological and pandemic threats, including vaccines, therapeutics, and diagnostics. BARDA anticipated multiple awards ranging from $750,000 to $8 million depending on project scope.
The contract funds a global antibacterial accelerator supporting multiple product developers advancing antimicrobial resistance countermeasures. Subcontractors and sub-awardees span diverse modalities: vaccine developers (Glaxosmithkline Biologicals, GlyProVac, Vaxdyn, Lumen Bioscience, Seres Therapeutics, Baxiva, Centauri Therapeutics, Immunartes, Clarametyx Biosciences, Limmatech Biologics), small-molecule antibiotic developers (Kinvard Bio, Helmholtz-Zentrum für Infektionsforschung, Basilea Pharmaceutica, Arrepath, Mutabilis), diagnostic companies (Day Zero Diagnostics, Chembio Diagnostic Systems, Uh-Oh Labs, Pearl Diagnostics, Prompt Diagnostics, Visby Medical, Zeteo Tech, Quantamatrix, Astradx, Meliolabs), bacteriophage and biotherapeutic developers (Locus Biosciences, Snipr Biome, Vedanta Biosciences, Peptilogics, Cellics Therapeutics), and accelerator and support organizations (Centre for Cellular and Molecular Platforms, Foundation for Innovative New Diagnostics, Institute for Life Science Entrepreneurship). Academic partners include Harvard College, Duke University, University of Alabama at Birmingham, Rhode Island Hospital, University of Oxford, University of Maryland Baltimore, Jackson Laboratory, and University of Melbourne. The contract supports development across infectious disease domains including gonorrhea, chlamydia, Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and other multidrug-resistant pathogens.
Subawards
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract 75A50122C00028?
75A50122C00028 was awarded to Trustees Of Boston University by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 1, 2022.
How much is contract 75A50122C00028 worth?
The government has obligated $150,780,000 on 75A50122C00028. Its potential value, with all options, is $300,000,000.
Was contract 75A50122C00028 competed?
The extent of competition for 75A50122C00028 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award